DK121709B - Analogifremgangsmåde til fremstilling af 5-(3,5-dimethylphenoxymethyl)-2-oxazolidoner. - Google Patents

Analogifremgangsmåde til fremstilling af 5-(3,5-dimethylphenoxymethyl)-2-oxazolidoner.

Info

Publication number
DK121709B
DK121709B DK235160AA DK235160A DK121709B DK 121709 B DK121709 B DK 121709B DK 235160A A DK235160A A DK 235160AA DK 235160 A DK235160 A DK 235160A DK 121709 B DK121709 B DK 121709B
Authority
DK
Denmark
Prior art keywords
dimethylphenoxymethyl
oxazolidones
preparation
analogous process
analogous
Prior art date
Application number
DK235160AA
Other languages
English (en)
Inventor
C Lunsford
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of DK121709B publication Critical patent/DK121709B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK235160AA 1959-06-19 1960-06-17 Analogifremgangsmåde til fremstilling af 5-(3,5-dimethylphenoxymethyl)-2-oxazolidoner. DK121709B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US821357A US3062827A (en) 1959-06-19 1959-06-19 5-(3', 5'-dialkylphenoxymethyl)-2-oxazolidones

Publications (1)

Publication Number Publication Date
DK121709B true DK121709B (da) 1971-11-22

Family

ID=25233163

Family Applications (1)

Application Number Title Priority Date Filing Date
DK235160AA DK121709B (da) 1959-06-19 1960-06-17 Analogifremgangsmåde til fremstilling af 5-(3,5-dimethylphenoxymethyl)-2-oxazolidoner.

Country Status (6)

Country Link
US (1) US3062827A (da)
BE (1) BE592006A (da)
CH (2) CH414640A (da)
DE (1) DE1163328B (da)
DK (1) DK121709B (da)
GB (1) GB888594A (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3251836A (en) * 1961-09-26 1966-05-17 Szabo Hnos Kessler & Cia S R L Oxazolidone derivatives and their preparation
US3331850A (en) * 1964-05-13 1967-07-18 Upjohn Co 5-(aryloxymethyl)-2-oxazolidinethiones
US4062862A (en) * 1975-07-04 1977-12-13 Nippon Chemiphar Co., Ltd. 5-Benzyl-2-oxazolidone derivatives and a process for producing the same
US7714006B1 (en) 2001-12-03 2010-05-11 King Pharmaceuticals Research & Development, Inc. Methods of modifying the bioavailability of metaxalone
US6407128B1 (en) 2001-12-03 2002-06-18 Elan Pharmaceuticals, Inc. Method for increasing the bioavailability of metaxalone
WO2003057132A2 (en) * 2002-01-07 2003-07-17 Sun Pharmaceutical Industries Limited Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
WO2003061552A2 (en) * 2002-01-14 2003-07-31 Sun Pharmaceutical Industries Limited Novel process for the preparation of substantially pure 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone
US6562980B1 (en) 2002-08-19 2003-05-13 Yung Shin Pharma Ind. Co., Ltd. Method for producing 5-aryloxymethyl-2-oxazolidinones
AU2003276688A1 (en) * 2002-09-02 2004-03-19 Sun Pharmaceutical Industries Limited Pharmaceutical composition of metaxalone with enhanced oral bioavailability
WO2006082597A2 (en) * 2005-01-24 2006-08-10 Fdc Limited Crystal modification of 5-substituted-2-oxazoiidone derivative and its process thereof
US20070088065A1 (en) * 2005-10-14 2007-04-19 Jie Du Metaxalone products, method of manufacture, and method of use
US20080292584A1 (en) * 2005-10-14 2008-11-27 Mutual Pharmaceutical Company, Inc. Metaxalone products, method of manufacture, and method of use
WO2007074477A2 (en) * 2005-12-29 2007-07-05 Dabur Pharma Limited Metaxalone polymorphs
WO2008006096A1 (en) * 2006-07-07 2008-01-10 Boehringer Ingelheim Chemicals, Inc. Metaxalone synthesis
WO2009085637A1 (en) * 2007-12-21 2009-07-09 Url Pharma, Inc. Amorphous metaxalone and amorphous dispersions thereof
US20090270469A1 (en) * 2008-04-25 2009-10-29 Auspex Pharmaceuticals, Inc. Substituted oxazolidinones
US8871793B2 (en) 2009-12-23 2014-10-28 Nuformix Limited Metaxalone cocrystals
US11918559B2 (en) 2019-06-25 2024-03-05 Primus Pharmceuticals, Inc. Reduced dose metaxalone formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2437390A (en) * 1948-03-09 Z-oxazolidone compounds and proc
US2617825A (en) * 1948-06-04 1952-11-11 Givaudan Corp Process for preparation of salts of 1-amino-2-haloethanes
DE883902C (de) * 1951-03-02 1953-07-23 Basf Ag Verfahren zur Herstellung von cyclischen Urethanen
DE917972C (de) * 1951-03-02 1954-09-16 Basf Ag Verfahren zur Herstellung von cyclischen Urethanen
US2770649A (en) * 1955-06-22 1956-11-13 Robins Co Inc A H o-methoxyphenoxy-2-hydroxy-propyl carbamates
US2895960A (en) * 1958-06-26 1959-07-21 Robins Co Inc A H Method of production of 5-o-methoxyphenoxymethyl-2-oxazolidone

Also Published As

Publication number Publication date
GB888594A (en) 1962-01-31
BE592006A (fr) 1960-12-19
CH414640A (de) 1966-06-15
DE1163328B (de) 1964-02-20
CH390916A (de) 1965-04-30
US3062827A (en) 1962-11-06

Similar Documents

Publication Publication Date Title
DK121709B (da) Analogifremgangsmåde til fremstilling af 5-(3,5-dimethylphenoxymethyl)-2-oxazolidoner.
DK105016C (da) Fremgangsmåde til fremstilling af 2,6-dichlorbenzonitril.
DK102795C (da) Fremgangsmåde til fremstilling af 1,2,3,4,4a,5,12,12a-octahydronaphthacenforbindelser.
DK104620C (da) Fremgangsmåde til fremstilling af 2,6-dichlorbenzonitril.
DK96111C (da) Fremgangsmåde til fremstilling af 3,4-dimethoxy-toluquinon.
DK99631C (da) Fremgangsmåde til fremstilling af 18,20-oxido-pregnaner.
DK100054C (da) Fremgangsmåde til fremstilling af 2,4-diamino-5-arylmethyl-pyrimidiner.
DK95218C (da) Fremgangsmåde til fremstilling af 1,1,1-trifluor-2-brom-2-klorætan.
DK94834C (da) Fremgangsmåde til fremstilling af 1,1,1-trifluor-2-brom-2-klorætan.
DK100877C (da) Fremgangsmåde til fremstilling af 18,20-lactoner af 20-hydroxy-pregnan-18-syrer.
DK98368C (da) Fremgangsmåde til fremstilling af 18,20-oxido-steroider.
DK96596C (da) Fremgangsmåde til fremstilling af 1,1,1-trifluor-2-brom-2-klorætan.
DK97589C (da) Fremgangsmåde til fremstilling af 12,13-dimethoxy-ibogamin.
DK119704B (da) Fremgangsmåde til fremstilling af 18,20-lactoner af 3-N-methylamino-20-hydroxypregnan-18-syrer.
DK94314C (da) Fremgangsmåde til fremstilling af 1-fenyl-3-metoksy-5-sulfanilamido-pyrazol-(1,2).
DK96883C (da) Fremgangsmåde til fremstilling af 3,11,20-triketo-Δ<16>-18-nor-pregnen.
DK98689C (da) Fremgangsmåde til fremstilling af 16α- eller 16β-methyl-3,17-diketo-11β-hydroxy-Δ<1,4>-androstadien.
DK99079C (da) Fremgangsmåde til fremstilling af 16α-ethinyl-11β,16β-dihydroxy-3-oxo-Δ<1,4>-androstadien.
DK98624C (da) Fremgangsmåde til fremstilling af 2-methyl-3-keto-11β,17β-dihydroxy-17α-ethinyl-Δ<1,4>-androstadien.
DK93949C (da) Fremgangsmåde til fremstilling af 6α-methyl-3,17-diketo-11β-hydroxy-Δ<1,4>-androstadien.
DK98121C (da) Fremgangsmåde til fremstilling af 18,11-lactoner af 11β-hydroxy-pregnan-18-syrer.
DK97401C (da) Fremgangsmåde til fremstilling af 6-methyl-3-keto-Δ<4,6>-steroidforbindelser.
DK101521C (da) Fremgangsmåde til fremstilling af 2,6-dimethyl-4-aminobenzamidderivater.
DK96116C (da) Fremgangsmåde til fremstilling af estere af 5,7-dihalogen-8-hydroxychinaldiner.
DK98630C (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinforbindelser.